Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.1K
Overview
83.1K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inconsistent definitions of radical resection in perioperative trials of non-small cell lung cancer: a scoping review.

Translational lung cancer research·2026
Same author

Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Prognostic Role of <sup>18</sup>F-FDG PET/CT in Oligometastatic Non-Small Cell Lung Cancer: Preliminary Results from Single Center.

Cancers·2026
Same author

Beyond the pelvis: diagnostic and surgical challenges of thoracic endometriosis syndrome - a retrospective cohort study of 41 patients.

Frontiers in medicine·2026
Same author

Transglutaminase 2 regulates innate immunity: mechanisms and therapeutic implications.

Oncoimmunology·2026
Same author

Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial.

Lung cancer (Amsterdam, Netherlands)·2026

Related Experiment Video

Updated: Dec 26, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.9K

Adoptive Cell Therapy-Harnessing Antigen-Specific T Cells to Target Solid Tumours.

Elżbieta Chruściel1, Zuzanna Urban-Wójciuk1, Łukasz Arcimowicz1

  • 1International Centre for Cancer Vaccine Science (ICCVS), University of Gdańsk, 80-309 Gdańsk, Poland.

Cancers
|March 19, 2020
PubMed
Summary

Adoptive cell therapies (ACT) show promise for solid tumors. This review explores challenges and strategies, including T cell selection and combination therapies, to improve anti-tumor potential for better cancer treatment outcomes.

Keywords:
T cell-based therapy of solid tumoursTCR therapyadoptive cell therapy of cancerantigen- specific T cellsimmunotherapyneoantigens

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.7K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.2K

Related Experiment Videos

Last Updated: Dec 26, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.9K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.7K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.2K

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Adoptive cell therapies (ACT) utilize T cells for cancer treatment.
  • Chimeric antigen receptor (CAR) T cells are successful in hematologic cancers.
  • Tumor-infiltrating lymphocytes (TILs) show efficacy in metastatic melanoma.

Purpose of the Study:

  • To review challenges in T cell-based immunotherapies for solid tumors.
  • To discuss methods for selecting optimal T cells based on tumor specificity and phenotype.
  • To present strategies for enhancing T cell anti-tumor activity, including combination therapies.

Main Methods:

  • Literature review of recent advancements in adoptive cell therapies.
  • Analysis of T cell selection criteria for solid tumor treatment.
  • Exploration of strategies to improve T cell efficacy in vivo.

Main Results:

  • ACT shows potential but faces challenges in solid tumors.
  • Effective T cell selection requires consideration of tumor specificity and phenotype.
  • Combination therapies and enhanced T cell engineering are key strategies for improvement.

Conclusions:

  • Overcoming challenges in ACT for solid tumors is crucial.
  • Optimizing T cell selection and function can improve therapeutic outcomes.
  • Future research should focus on innovative strategies to enhance T cell-based cancer immunotherapy.